FREEPORT-MCMORAN INC (FCX)       30.05  -0.57 (-1.86%)

30.05  -0.57 (-1.86%)

US35671D8570 - Common Stock - After market: 30.09 +0.04 (+0.13%)


Fundamental Rating

Taking everything into account, FCX scores 6 out of 10 in our fundamental rating. FCX was compared to 979 industry peers in the Metals & Mining industry. While FCX has a great profitability rating, there are some minor concerns on its financial health. FCX has a correct valuation and a medium growth rate.




Profitability

Profitability Rating


FCX has a Return On Assets of 10.47%. This is amongst the best returns in the industry. The industry average is -11.61%. FCX outperforms 90% of its industry peers.
FCX has a Return On Equity of 34.41%. This is amongst the best returns in the industry. The industry average is 11.99%. FCX outperforms 83% of its industry peers.

FCX has a Profit Margin of 20.79%. This is amongst the best returns in the industry. The industry average is 3.95%. FCX outperforms 81% of its industry peers.
FCX has a very good Piotroski-F score of 9.00. This indicates a great health and profitability for FCX.
VS Industry

ROA (10.47%) VS Industry: 90% outperformed.

-84,375.53
529.59

ROE (34.41%) VS Industry: 83% outperformed.

0.04
286.16

Profit Margin (20.79%) VS Industry: 81% outperformed.

-1,474,317.78
16,876.10

Valuation

Valuation Rating


With a Price/Earnings Ratio of 8.14, the valuation of FCX can be described as very reasonable.
With a Forward Price/Earnings Ratio of 9.86, the valuation of FCX can be described as very reasonable.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FCX's Price/Earning Ratio is in line with the industry average which is at 8.88.

When comparing the current price to the book value of FCX, we can conclude it is valued correctly. It is trading at 2.93 times its book value.
When comparing the Enterprise Value to EBITDA ratio of FCX to the average industry ratio of 4.06, FCX is valued in line with its industry peers.
When comparing the price book ratio of FCX to the average industry price book ratio of 1.60, FCX is valued more expensive than its industry peers.
VS Industry

Price/Earnings (8.14) VS Industry: 52% outperformed.

415.00
0.12

Price/Book (2.93) VS Industry: 29% outperformed.

218.38
0.03

Enterprise Value/ EBITDA (3.88) VS Industry: 53% outperformed.

478.02
0.17

Growth

Growth Rating


The Earnings Per Share has grown by an impressive 202.46% over the past year.
The Earnings Per Share has been growing by 73.34% on average over the past 5 years. This is a very strong growth
FCX shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.37%.
The Earnings Per Share is expected to decrease by -5.98% on average over the next 5 years.

Measured over the past 5 years, FCX shows a small growth in Revenue. The Revenue has been growing by 9.03% on average per year.
Based on estimates for the next 5 years, FCX will show a decrease in Revenue. The Revenue will decrease by -0.69% on average per year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS73.34% 27.79% 202.46% 25.48% -1.34% -1.41% -5.98%
Revenue9.03% 7.04% 51.37% 16.51% 5.96% 2.16% -0.69%

Health

Health Rating


FCX has a Current Ratio of 2.37. This indicates that FCX is financially healthy and has no problem in meeting its short term obligations.
The Piotroski-F score of FCX is 9.00. This is a very strong score and indicates great health and profitability for FCX.
A Quick Ratio of 1.68 indicates that FCX should not have too much problems paying its short term obligations.
An Altman-Z score of 1.97 indicates that FCX is not a great score, but indicates only limited risk for bankruptcy at the moment.

The Altman-Z score is in line with the industry averages, which is at 2.85.
Compared to an average industry Current Ratio of 3.37, FCX is worse placed to pay its short term obligations than its industry peers.
Compared to an average industry Quick Ratio of 3.14, FCX is worse placed to pay its short term obligations than its industry peers.
FCX has one of the worst Debt to Equity ratios in its industry. 94% of its industry peers require less debt for financing their operations.
VS Industry

Debt/Equity (0.56) VS Industry: 6% outperformed.

148.45
-90.09

Quick Ratio (1.68) VS Industry: 35% outperformed.

0.00
485.30

Current Ratio (2.37) VS Industry: 38% outperformed.

0.00
485.30

Altman-Z (1.97) VS Industry: 43% outperformed.

-63,945.35
2,215.99

Dividend

Dividend Rating


On average, the dividend of FCX grows each year by 14.47%, which is quite nice.
FCX pays out 10.77% of its income as dividend. This is a sustainable payout ratio.
FCX has paid a dividend for at least 10 years, which is a reliable track record.
With a Yearly Dividend Yield of 1.06%, FCX has a reasonable but not impressive dividend return.

With a Dividend Yield of 1.06, FCX pays less dividend than the industry average, which is at 2.66. 86% of the companies listed in the same industry pay a better dividend than FCX!
Compared to an average S&P500 Dividend Yield of 2.39, FCX's dividend is way lower than the S&P500 average.
FCX's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (1.06%) VS Industry: 14% outperformed.

0.05
20.38
FCX Daily chart

FREEPORT-MCMORAN INC30.05

NYSE:FCX (8/9/2022, 6:38:01 PM)-0.57 (-1.86%)

After market: 30.09 +0.04 (+0.13%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Metals & Mining
Earnings (Last) 07-21 2022-07-21/bmo Earnings (Next) 10-19 2022-10-19
Ins Owners 0.4% Inst Owners 78%
Market Cap 43.55B Analysts 77.04
Valuation
PE 8.14 Fwd PE 9.86
PEG (NY) 0.32 PEG (5Y) 0.11
P/S 1.77 P/B 2.93
EV/EBITDA 3.88
Profitability
ROA 10.47% ROE 34.41%
PM 20.79 Asset Turnover 0.5
Growth
EPS 1Y 202.46% EPS 3Y 27.79%
EPS 5Y 73.34% EPS growth Q2Q 109.8%
EPS Next Y 25.48% EPS Next 2Y -1.34%
EPS Next 3Y -1.41% EPS Next 5Y -5.98%
Revenue growth 1Y 51.37% Revenue growth 3Y 7.04%
Revenue growth 5Y 9.03% Revenue growth Q2Q 36.14%
Revenue Next Year 16.51% Revenue Next 2Y 5.96%
Revenue Next 3Y 2.16% Revenue Next 5Y -0.69%
Health
Current Ratio 2.37 Quick Ratio 1.68
Altman-Z 1.97 F-Score 9
Debt/Equity 0.56
Dividend
Dividend Yield 1.06% Dividend Growth 14.47%
DP 10.77% Ex-Date 07-14 2022-07-14 (0.15)

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA